Yang Xu

Physiologically‐based pharmacokinetic modelling to predict oprozomib CYP3A drug–drug interaction potential in patients with advanced malignancies

K. Papadopoulos, A. Tsimberidou, A. Mita, 2018, British journal of clinical pharmacology.

Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells

Yang Xu, Leiming Xia, Yi Wang, 2022, Translational oncology.

A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females

Edward Lee, D. Mikol, Apinya Vutikullird, 2019, CNS Drugs.